Blogs about: Biogen Idec
Featured Blog
Biogen Idec and Biovitrum AB alliance launches trial
On October 19 2009 Biogen Idec and Biovitrum AB announced the start of a registrational clinical trial in hemophilia B patients with their long-acting, fully-recombinant Factor IX Fc fusion protein (r… more →
Silico Research
Biovitrum Advances Novel Factor VIII Long-Acting Hemophilia A Therapy into Clinical Trials
wrote 3 weeks ago: Stockholm, Sweden – Dec 15, 2009 – Biovitrum AB (publ) (STO: BVT) today announced that t … more →
Tysabri PML CASES JUMP!!
wrote 2 months ago: I was shocked to discover that this was reported a week ago. As a Tysabri patient I’d say this … more →
Biogen Idec and Biovitrum AB alliance launches trial
wrote 2 months ago: On October 19 2009 Biogen Idec and Biovitrum AB announced the start of a registrational clinical tri … more →
Elan cures Tysabri breach
wrote 3 months ago: Elan has announced that it has cured the breach of the Tysabri collaboration agreement with Biogen r … more →
Jonhson & Johnson seeks Elan cut
wrote 3 months ago: The Financial Times is reporting that Johnson & Johnson is negotiating to reduce the price of it … more →
Evotec announces research agreement with Biogen Idec
wrote 3 months ago: Evotec has announced that it has entered into a research agreement with Biogen Idec. Evotec will us … more →
Bayer’s Bold New Bet Fails to Rain on Spectrum Pharmaceuticals
— 1 comment
wrote 4 months ago: By Michael D. Becker Despite recent progress and the availability of novel therapies, radiation is s … more →
Elan files declaratory suit against Biogen Idec
wrote 4 months ago: Elan has announced that it has filed suit against Biogen Idec in Federal Court in New York seeking d … more →
Biogen Idec and Acorda Therapeutics announce collaboration to develop MS therapy
wrote 6 months ago: Biogen Idec and Acorda Therapeutics have announced that they have entered into an exclusive collabor … more →
MS drug linked to lethal brain infection
wrote 6 months ago: “A new case of a rare, often lethal, brain infection has been linked to the multiple sclerosis … more →
Arbitration panel reaffirms Biogen Idec's contractual right under collaboration with Genentech
wrote 6 months ago: Biogen Idec has announced that an arbitration panel has issued its decision concerning the company … more →
Where Might Genentech Investors Redeploy $47 Billion?
wrote 9 months ago: Following a spate of high profile clinical setbacks and regulatory delays that sent the sector into … more →
Wednesday Brain Dump: February 25, 2009
wrote 10 months ago: The question this week: a shot in the arm or a kick in the teeth? A shot in the arm for: Fewer shots … more →
Wednesday Brain Dump: February 11, 2009
wrote 10 months ago: Deep Appreciation:for Phillip Terrence Ragon, founder and sole proprietor of database-software provi … more →
multiple sclerosis - weapons of MS destruction?
— 1 comment
wrote 11 months ago: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (brain, spinal … more →
Web Interventions for Behavorial Modifications
wrote 1 year ago: Quality of life. This is almost become like the “tissue” in the health care space. A t … more →
Not another PML case...
wrote 1 year ago: Biogen Idec announced on Wednesday (Oct. 29, 2008) that another case of progressive multifocal leuko … more →
Tysabri's Manufacturer Defends Its Drug
— 1 comment
wrote 1 year ago: Biogen Idec says Tysabri will remain on the market, despite the two cases of PML that were revealed … more →
Two More Tysabri Patients Have Developed Brain Disease
wrote 1 year ago: From the Boston Globe and the SEC web site The first cases of a rare brain disease have been diagnos … more →
